First published 10/1/2026, 2:22:15 AM · Last updated 10/1/2026, 2:22:15 AM

Interleukin-6 May Be Associated with Mitochondrial Dysfunction Through Signal Transducer and Activator of Transcription-3 in Patients with Type 2 Diabetes Mellitus

A journal article (Publisher: Mustansiriyah University) reports that interleukin-6 may be associated with mitochondrial dysfunction via STAT3 in patients with type 2 diabetes mellitus. No additional study details, location, or results were included in the supplied source data.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 3/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The reported association could be relevant to understanding mechanisms of mitochondrial dysfunction in patients with type 2 diabetes.

Sources

Interleukin-6 May Be Associated with Mitochondrial Dysfunction Through Signal Transducer and Activator of Transcription-3 in Patients with Type 2 Diabetes Mellitus

Report an issue